End-of-day quote
Shenzhen S.E.
06:00:00 2024-04-29 pm EDT
|
5-day change
|
1st Jan Change
|
8.62
CNY
|
-.--%
|
|
+2.50%
|
-13.19%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
2,186
|
2,802
|
3,060
|
4,849
|
4,291
|
4,693
|
Enterprise Value (EV)
1 |
2,480
|
2,846
|
3,036
|
4,756
|
3,764
|
4,118
|
P/E ratio
|
24.7
x
|
30.2
x
|
29
x
|
39.6
x
|
26.7
x
|
28.4
x
|
Yield
|
0.58%
|
1.16%
|
1.21%
|
0.88%
|
1.19%
|
1.24%
|
Capitalization / Revenue
|
1.98
x
|
2.47
x
|
2.44
x
|
3.51
x
|
2.94
x
|
2.75
x
|
EV / Revenue
|
2.24
x
|
2.5
x
|
2.42
x
|
3.44
x
|
2.58
x
|
2.42
x
|
EV / EBITDA
|
12.5
x
|
19.1
x
|
16
x
|
23.3
x
|
19.1
x
|
17.5
x
|
EV / FCF
|
-22.1
x
|
-10.4
x
|
9.64
x
|
41.8
x
|
-37.4
x
|
109
x
|
FCF Yield
|
-4.53%
|
-9.65%
|
10.4%
|
2.39%
|
-2.67%
|
0.92%
|
Price to Book
|
2.54
x
|
2.56
x
|
2.51
x
|
3.8
x
|
2.44
x
|
2.61
x
|
Nbr of stocks (in thousands)
|
422,000
|
422,000
|
422,000
|
422,000
|
472,621
|
472,621
|
Reference price
2 |
5.180
|
6.640
|
7.250
|
11.49
|
9.080
|
9.930
|
Announcement Date
|
3/28/19
|
4/2/20
|
3/29/21
|
4/29/22
|
4/7/23
|
3/28/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
1,105
|
1,137
|
1,254
|
1,381
|
1,461
|
1,705
|
EBITDA
1 |
198.6
|
148.7
|
190
|
204
|
197.3
|
234.7
|
EBIT
1 |
137.9
|
93.58
|
125.4
|
134.1
|
127.6
|
149
|
Operating Margin
|
12.48%
|
8.23%
|
10%
|
9.71%
|
8.73%
|
8.74%
|
Earnings before Tax (EBT)
1 |
131.1
|
126.7
|
135.1
|
152.8
|
152.4
|
175.4
|
Net income
1 |
88.03
|
92.32
|
106
|
121.4
|
145
|
164.7
|
Net margin
|
7.97%
|
8.12%
|
8.45%
|
8.79%
|
9.92%
|
9.66%
|
EPS
2 |
0.2100
|
0.2200
|
0.2500
|
0.2900
|
0.3400
|
0.3500
|
Free Cash Flow
1 |
-112.4
|
-274.8
|
314.8
|
113.9
|
-100.6
|
37.87
|
FCF margin
|
-10.17%
|
-24.18%
|
25.1%
|
8.25%
|
-6.89%
|
2.22%
|
FCF Conversion (EBITDA)
|
-
|
-
|
165.68%
|
55.81%
|
-
|
16.13%
|
FCF Conversion (Net income)
|
-
|
-
|
297.1%
|
93.81%
|
-
|
22.98%
|
Dividend per Share
2 |
0.0300
|
0.0770
|
0.0880
|
0.1010
|
0.1080
|
0.1230
|
Announcement Date
|
3/28/19
|
4/2/20
|
3/29/21
|
4/29/22
|
4/7/23
|
3/28/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
294
|
44.4
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
-
|
-
|
23.7
|
92.8
|
527
|
575
|
Leverage (Debt/EBITDA)
|
1.481
x
|
0.2982
x
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-112
|
-275
|
315
|
114
|
-101
|
37.9
|
ROE (net income / shareholders' equity)
|
10.7%
|
9.64%
|
9.06%
|
9.69%
|
9.46%
|
9.24%
|
ROA (Net income/ Total Assets)
|
4.5%
|
2.79%
|
3.33%
|
3.37%
|
2.97%
|
3.46%
|
Assets
1 |
1,958
|
3,314
|
3,180
|
3,606
|
4,889
|
4,766
|
Book Value Per Share
2 |
2.040
|
2.590
|
2.880
|
3.020
|
3.720
|
3.800
|
Cash Flow per Share
2 |
0.6300
|
0.9000
|
1.330
|
1.540
|
1.980
|
1.220
|
Capex
1 |
115
|
159
|
56.9
|
94.2
|
108
|
71.1
|
Capex / Sales
|
10.39%
|
13.98%
|
4.54%
|
6.83%
|
7.41%
|
4.17%
|
Announcement Date
|
3/28/19
|
4/2/20
|
3/29/21
|
4/29/22
|
4/7/23
|
3/28/24
|
|
1st Jan change
|
Capi.
|
---|
| -13.19% | 563M | | +14.67% | 64.83B | | -1.61% | 46.29B | | +14.58% | 40.05B | | +20.84% | 26.72B | | +1.21% | 17.45B | | -21.87% | 15.82B | | +1.11% | 15.02B | | -10.99% | 14.73B | | -20.61% | 13.34B |
Other Specialty Chemicals
|